Supplementary Figure 4 from Human Breast Cancer Cells Harboring a Gatekeeper T798M Mutation in HER2 Overexpress EGFR Ligands and Are Sensitive to Dual Inhibition of EGFR and HER2

Supplementary Figure 4 - PDF file 152K, T798M mutant expression in as low as 5% of cells is sufficient to confer resistance